Migraine Trial, Recruiting NCT05418218 Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University Condition: Migraine
Back to Migraine

Migraine Trial, Recruiting

NCT05418218
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are willing and able to give written consent to participate in the study before any study procedures begin
  • You are male or female, aged 4 to 99 years old at your first visit
  • You have been diagnosed with a headache condition that meets recognised international headache diagnostic standards, such as migraine, tension-type headaches, other headache types, or vestibular migraine (a type of migraine that can involve dizziness)

Who may not be able to join:

  • People who are unable to fill in tracking tools such as a headache diary
  • People who are unable or unwilling to attend regular follow-up appointments over a longer period of time

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Kaiming Liu, Doctor, headache specialist clinic of the Second Affiliated Hospital of Zhejiang Medical University

Phone: +8615068862055

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
12 July 2021
Est. completion
31 December 2082

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Days of Migraine; Moderate / Severe Headache Days; Migraine Attack

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov